These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21215126)

  • 21. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience.
    Rutvisuttinunt W; Arroyo MA; Assawadarachai V; Poltavee K; McCutchan FE; Tovanabutra S; Kijak G; Kim JH; Paris RM; de Souza M
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):333-9. PubMed ID: 23082585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand.
    Leelawiwat W; Young NL; Chaowanachan T; Ou CY; Culnane M; Vanprapa N; Waranawat N; Wasinrapee P; Mock PA; Tappero J; McNicholl JM
    J Virol Methods; 2009 Feb; 155(2):109-17. PubMed ID: 18952125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
    Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
    Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
    Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
    Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on genotypic resistance mutations to antiretroviral drugs on HIV strains of treated and treatment-naive HIV-1 infectious patients in Hubei province].
    Wang XQ; Tong X; Tang H; Liu PP; Zhang W; Yang RG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1112-5. PubMed ID: 18396668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.
    Elbeik T; Hoo BS; Campodonico ME; Dileanis J; Fay FF; Bortolozzi RL; Benetti MS; Fay OH; Marlowe N; Petrauskene O; Chernoff D; Smith L; Ng VL
    J Hum Virol; 2001; 4(6):317-28. PubMed ID: 12082398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the drug resistance situation among recently infected HIV-1 patients in Dehong].
    Wang MJ; Duan S; Xiang LF; Yang YC; Tu YQ; Wang JB; Yao J; Qi J; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):905-8. PubMed ID: 19173856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.
    McNulty A; Jennings C; Bennett D; Fitzgibbon J; Bremer JW; Ussery M; Kalish ML; Heneine W; García-Lerma JG
    J Clin Microbiol; 2007 Feb; 45(2):517-21. PubMed ID: 17166967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an in-house HIV-1 drug resistance genotypic testing for using dried blood spot specimens in China.
    Zhao H; Liao L; Xing H; Wang Z; Su B; Liu J; Wu J; Feng Y; He C; Ruan Y; Shao Y
    Curr HIV Res; 2015; 13(2):109-16. PubMed ID: 25495996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.
    Wei X; Youngpairoj AS; Garrido C; Zahonero N; Corral A; de Mendoza C; Heneine W; Johnson JA; Garcia-Lerma JG
    J Clin Virol; 2011 Feb; 50(2):148-52. PubMed ID: 21130027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
    Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A
    HIV Med; 2008 Aug; 9(7):448-51. PubMed ID: 18840150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of HIV-1 RNA in dried blood and plasma spots.
    Reigadas S; Schrive MH; Aurillac-Lavignolle V; Fleury HJ
    J Virol Methods; 2009 Oct; 161(1):177-80. PubMed ID: 19523984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.
    Johannessen A; Garrido C; Zahonero N; Naman E; de Mendoza C
    J Antimicrob Chemother; 2011 Feb; 66(2):260-4. PubMed ID: 21115444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.